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abstract
 
In an earlier investigation, we demonstrated that the likelihood of interaction of a positively charged
 
ryanoid, 21-amino-9
 
a
 
-hydroxyryanodine, with the sarcoplasmic reticulum Ca
 
2
 
1
 
-release channel (ryanodine recep-
 
tor, RyR) is dependent on holding potential (Tanna, B., W. Welch, L. Ruest, J.L. Sutko, and A.J. Williams. 1998. 
 
J.
Gen. Physiol.
 
 112:55–69) and suggested that voltage dependence could result from either the translocation of the
charged ligand to a site within the voltage drop across the channel or a voltage-driven alteration in receptor afﬁnity.
We now report experiments that allow us to assess the validity of these alternate mechanisms. Ryanodol is a neutral
ryanoid that binds to RyR and induces modiﬁcation of channel function. By determining the inﬂuence of trans-
membrane potential on the probability of channel modiﬁcation by ryanodol and the rate constants of ryanodol as-
sociation and dissociation, we demonstrate that the inﬂuence of voltage is qualitatively the same for both the neutral
and positively charged ryanoids. These experiments establish that most, if not all, of the modiﬁcation of ryanoid in-
teraction with RyR by transmembrane holding potential results from a voltage-driven alteration in receptor afﬁnity.
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INTRODUCTION
 
Ryanodine is a plant alkaloid that binds with high afﬁn-
ity and speciﬁcity to a class of intracellular membrane
 
Ca
 
2
 
1
 
-release channels (Sutko et al., 1997). As a conse-
quence of this interaction, these channels are com-
monly referred to as ryanodine receptors (RyRs).
 
1
 
 Ry-
anodine has proven to be a useful tool in establishing
the molecular identity of the Ca
 
2
 
1
 
-release channel (Lai
et al., 1988a,b), in the characterization of the function
of the receptor as a channel, and in the elucidation of
its role in Ca
 
2
 
1
 
 signaling processes in a wide range of
systems (Bazotte et al., 1991; Foskett and Wong, 1991;
Swann, 1992; Walz et al., 1995; Ullmer et al., 1996). The
binding of ryanodine to its high afﬁnity site on RyR ini-
tiates a marked change in channel function; rates of
permeant ion translocation are altered and open prob-
 
ability (
 
P
 
o
 
) is increased dramatically. The modiﬁcation
of RyR ion handling by ryanodine is the consequence
of the alteration of a number of processes governing
cation translocation. The reduction in single-channel
conductance observed on the binding of ryanodine to
the RyR channel with either divalent or monovalent in-
organic cations as the permeant species reﬂects alter-
ations in both the relative permeability of ions and the
afﬁnity of sites within the conduction pathway for these
ions (Lindsay et al., 1994). It seems likely that the bind-
ing of ryanodine to the channel induces a conforma-
tional change in the protein that in turn modiﬁes the
manner in which permeant ions interact with the con-
duction pathway (Lindsay et al., 1994).
 
The kinetic parameters of the ryanodine–RyR interac-
tion are traditionally determined by monitoring the
 
binding of [
 
3
 
H]ryanodine to populations of receptors,
either in intact membrane vesicles, or after receptor pu-
riﬁcation (Fleischer et al., 1985; Pessah et al., 1986; Lai
et al., 1989; Chu et al., 1990; Holmberg and Williams,
1990; Needleman and Hamilton, 1997; Murayama et al.,
1999). We have recently developed methods that permit
the investigation of the kinetic parameters of the inter-
action of ryanoids with individual RyR channel proteins
under voltage clamp conditions. These experiments are
based on the observation that (a) the interaction of a ry-
anoid with the channel induces a distinct modiﬁcation
of channel function and (b) alterations in ryanoid struc-
ture produce variations in binding kinetics. Consistent
with the very slow rates of dissociation monitored for
[
 
3
 
H]ryanodine in binding assays, the interaction of ry-
anodine with a single RyR channel is irreversible on the
timescale of a single-channel experiment (Rousseau et
al., 1987; Lindsay et al., 1994; Tinker et al., 1996); ryano-
 
Address correspondence to Alan J. Williams, Department of Cardiac
Medicine, National Heart & Lung Institute, Imperial College of Sci-
ence, Technology & Medicine, Dovehouse Street, London SW3 6LY,
United Kingdom. Fax: 44 0 171 823 3392; E-mail: a.j.williams@ic.ac.uk
 
1
 
Abbreviation used in this paper:
 
 RyR, ryanodine receptor. 
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Voltage Dependence of Ryanoid Binding to Ryanodine Receptor
 
dine “locks” the channel in a high-
 
P
 
o
 
, modiﬁed-conduc-
tance state. Modiﬁcation of the structure of ryanodine
yields ryanoids that compete with ryanodine for the
high afﬁnity site on the RyR channel (Welch et al., 1994,
1996; Bidasee and Besch, 1998; Humerickhouse et al.,
1994) and induce high-
 
P
 
o
 
, modiﬁed-conductance states.
However, the kinetics of the interaction of some of these
ligands with single RyR channels is much faster than
those of ryanodine. In the continued presence of the ry-
anoid, we observe transitions between periods of nor-
mal channel gating and ion translocation and periods
of modiﬁed channel function during which the ryanoid
is bound (Tinker et al., 1996; Tanna et al., 1998). We
have characterized the interaction of one such ryanoid,
21-amino-9
 
a
 
-hydroxyryanodine, with the sheep cardiac
isoform of the RyR channel and have identiﬁed a num-
ber of novel features (Tanna et al., 1998). Variations in
21-amino-9
 
a
 
-hydroxyryanodine binding to single chan-
nels with changing concentrations of the ryanoid indi-
cate that modiﬁcations of RyR channel function in-
duced by this ryanoid result from the interaction of a
single molecule of the ryanoid with each channel pro-
tein. Related experiments demonstrated that 21-amino-
9
 
a
 
-hydroxyryanodine has access to its binding site only
in open conformations of the channel protein, that the
ryanoid binding site can only be reached from the cyto-
solic side of the channel, and that the interaction of the
ryanoid with its binding site is inﬂuenced strongly by
transmembrane voltage (Tanna et al., 1998).
The quantitative determination of the voltage depen-
dence of the interaction of 21-amino-9
 
a
 
-hydroxyryano-
dine with RyR indicates that approximately two positive
charges move through the voltage drop across the chan-
nel during the activation of 21-amino-9
 
a
 
-hydroxyryano-
dine binding by voltage (Tanna et al., 1998). Both the rate
of association of the ryanoid with the receptor and the
rate of dissociation from the receptor are inﬂuenced by
voltage. A likely source of the voltage dependence of this
reaction would involve the translocation of 21-amino-9
 
a
 
-
hydroxyryanodine (net charge 
 
1
 
1) to a binding site
within the voltage drop across the channel. If all the volt-
age dependence of the interaction arises in this way, ei-
ther two molecules of the ryanoid would need to be
translocated across the entire voltage drop, or several ry-
anoid molecules could interact with sites located nearer
the cytosolic entry to the voltage drop. Neither of these
possibilities is consistent with our observation that other
aspects of the interaction of 21-amino-9
 
a
 
-hydroxyryano-
dine with RyR can be described in terms of a bimolecu-
lar reaction (Tanna et al., 1998). An alternative explana-
tion is that the measured voltage dependence results not
from the movement of the charged ryanoid into an elec-
tric ﬁeld, but from a voltage-driven movement of charge
within the RyR channel protein that produces a confor-
mational change in the channel protein and switches
 
the ryanoid binding site between two states with differ-
ent afﬁnities (Tanna et al., 1998). The elucidation of the
mechanism underlying the dependence on transmem-
brane voltage of the interaction of 21-amino-9
 
a
 
-hydroxy-
ryanodine with RyR is of interest in its own right, but
may also provide information on the location of the ry-
anodine binding site in RyR. For example, translocation
of 21-amino-9
 
a
 
-hydroxyryanodine into the voltage drop
across the channel would suggest that the binding site is
within the conduction pathway of the RyR channel.
In this communication we have addressed these issues
by investigating the inﬂuence of transmembrane voltage
on the interaction of a neutral ryanoid, ryanodol, with
single RyR channels. Our experiments demonstrate that
ryanodol displays the same qualitative voltage depen-
dence as the positively charged 21-amino-9
 
a
 
-hydroxyry-
anodine and are consistent with the proposal that most,
if not all, of the inﬂuence of voltage on the interaction
of ryanoids with the RyR channel is derived from a volt-
age-driven alteration in the afﬁnity of the receptor.
 
MATERIALS AND METHODS
 
Materials
 
Phosphatidylethanolamine was supplied by Avanti Polar Lipids,
Inc. and phosphatidylcholine by Sigma-Aldrich. [
 
3
 
H]Ryanodine
was purchased from New England Nuclear Ltd. Aqueous count-
ing scintillant was purchased from Packard. Standard chemicals
were obtained as the best available grade from BDH Ltd. or
Sigma-Aldrich. Ryanodol was synthesized as described earlier
(Wiesner, 1972; Deslongchamps et al., 1990) and stored as a
stock solution in 50% ethanol at 
 
2
 
20
 
8
 
C.
 
Isolation of Sheep Cardiac Heavy Sarcoplasmic Reticulum 
Membrane Vesicles and Solubilization and Separation of 
the Ryanodine Receptor
 
Heavy sarcoplasmic reticulum (HSR) membrane vesicles were
prepared using procedures described earlier (Sitsapesan and Wil-
liams, 1990). Sheep hearts were collected from a local abattoir in
ice-cold cardioplegic solution (Sitsapesan and Williams, 1990). A
mixed membrane fraction was obtained by differential centrifu-
gation after homogenization of the ventricular septum and left
ventricle free wall. The mixed membrane vesicles were further
fractionated by sucrose density gradient centrifugation and the
HSR fraction was collected at the 30/40% (wt/vol) interface.
The HSR fraction was resuspended in 0.4 M KCl before sedimen-
tation at 100,000 
 
g
 
. The resulting pellet was resuspended in 0.4 M
sucrose, 5 mM HEPES, titrated to pH 7.2 with hydroxymethyl me-
thylamine (Tris). HSR membrane vesicles were solubilized with
3-[(3-cholamidopropyl)-dimethylammonio]-1-propane sulfonate
(CHAPS) and RyR was isolated and reconstituted into unilamel-
lar liposomes for incorporation into planar phospholipid bilay-
ers, as described previously (Lindsay and Williams, 1991).
 
Planar Phospholipid Bilayers
 
Phospholipid bilayers were formed from suspensions of phos-
phatidylethanolamine in 
 
n
 
-decane (35 mg/ml) across a 200-
 
m
 
m
diameter hole in a polystyrene copolymer partition that sepa-
rated two chambers referred to as cis (0.5 ml) and trans (1.0 ml).
The trans chamber was held at virtual ground while the cis cham- 
3
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ber could be clamped at holding potentials
 
 
 
relative to ground.
Current ﬂow across the bilayer was monitored using an opera-
tional ampliﬁer as a current–voltage converter (Miller, 1982). Bi-
layers were formed with solutions containing 600 mM KCl, 20
mM HEPES, titrated to pH 7.4 with KOH, resulting in a solution
containing 610 mM K
 
1
 
 in both chambers. An osmotic gradient
was created by the addition of an aliquot (50–100 
 
m
 
l) of 3 M KCl
to the cis chamber. Proteoliposomes were added to the cis cham-
ber and stirred. Under these conditions, channels usually incor-
porated into the bilayer within 2–3 min. If channels did not in-
corporate, a second aliquot of 3 M KCl could be added to the cis
chamber. After channel incorporation, further fusion was pre-
vented by perfusion of the cis chamber with 610 mM K
 
1
 
. Chan-
nel proteins incorporate into the bilayer in a ﬁxed orientation so
that the cytosolic face of the channel is exposed to the solution in
the cis chamber and the luminal face of the channel to the solu-
tion in the trans chamber. Single channel 
 
P
 
o
 
 was increased by the
addition of up to 200 
 
m
 
M EMD 41000 to the cytosolic face of the
channel (McGarry and Williams, 1994; Tanna et al., 1998). Only
bilayers containing a single channel were used in the experi-
ments described in this communication. Experiments were car-
ried out at room temperature (21 
 
6
 
 2
 
8
 
C). The interactions of ry-
anodol with the channel were studied by adding the indicated
concentration to the solution at the cytosolic face of the bilayer.
 
Single Channel Data Acquisition
 
Single channel current ﬂuctuations were displayed on an oscillo-
scope and stored on Digital Audio Tape. For analysis, data were
replayed, ﬁltered at 1 kHz with an eight-pole Bessel ﬁlter, and
digitized at 4 kHz using Satori V3.2 (Intracel). Single channel
current amplitudes and lifetimes were measured from digitized
data. The representative traces shown in the ﬁgures were ob-
tained from digitized data acquired with Satori V3.2 and trans-
ferred as an HPGL graphics ﬁle to a graphics software package
(CorelDraw; Corel Systems Corp.) for annotation and printing.
 
Monitoring the Interaction of Ryanodol with Single Channels
 
Ryanodol binds to the high afﬁnity ryanodine binding site on the
SR Ca
 
2
 
1
 
-release channel and induces modiﬁcations of channel
function; channel conductance is reduced and 
 
P
 
o
 
 increases
(Tinker et al., 1996). The interaction kinetics of ryanodol are suf-
ﬁciently rapid that, in the continued presence of the ryanoid, we
observe repeated transitions between periods of modiﬁed chan-
nel function and periods of normal gating and conductance. In
previous studies, we have established that the interaction of 21-
amino-9
 
a
 
-hydroxyryanodine and the resulting modiﬁcation of
channel function can be described by a simple bimolecular reac-
tion scheme (Tanna et al., 1998). Consistent with this scheme,
dwell times of the RyR channel in the ryanodol-modiﬁed and
-unmodiﬁed gating states are described by single exponentials,
the rate of association of ryanodol with its receptor varies with ry-
anodol concentration while the rate of dissociation of ryanodol
from its receptor is independent of ligand concentration (data
not shown). As a consequence, apparent rate constants for the
association (
 
k
 
on
 
) and dissociation (
 
k
 
off
 
) of ryanodol can be deter-
mined from the mean dwell times in the unmodiﬁed and modi-
ﬁed conductance states (Eqs. 1 and 2):
 
(1)
 
and
 
(2)
kon tunmod ()
1 – =
koff tmod ()
1 – . =
 
Dwell times and the probability that the channel is in the ry-
anoid-modiﬁed state (
 
P
 
mod
 
) were determined using a pattern rec-
ognition program as described in Tanna et al. (1998). To obtain
sufﬁcient events, these parameters were obtained from steady
state recordings lasting at least 6 min.
 
The Modiﬁcation of the Interaction of Ryanodol with 
RyR by Voltage
 
If the transition between the normal gating state of the RyR and
the modiﬁed state resulting from the interaction of ryanodol is
dependent on holding potential, 
 
P
 
mod
 
 will be determined by the
Boltzmann distribution,
 
(3)
 
where 
 
F 
 
is the Faraday constant, V is the transmembrane voltage,
 
R
 
 is the gas constant, 
 
T
 
 is temperature (
 
8
 
K), 
 
z
 
t
 
 is the voltage de-
pendence of the occurrence of the ryanoid modiﬁed state, 
 
D
 
G
 
i 
 
is
the difference in free energy of the unmodiﬁed and ryanoid-
modiﬁed states, and 
 
D
 
G
 
i
 
/RT
 
 is an expression of the equilibrium
of the reaction at a holding potential of 0 mV.
For such a relationship, the rate constants at a given voltage
will be described as follows:
 
(4)
(5)
 
where 
 
k
 
(V) and 
 
k
 
(0) are the rate constants at a particular voltage
and at 0 mV, respectively, and 
 
z
 
 is the valence of the appropriate
reaction. Plots of the natural logarithm of 
 
k
 
on
 
 and 
 
k
 
off
 
 against hold-
ing potential should be linear with slopes 
 
z
 
on
 
F/RT
 
 and 
 
2
 
z
 
off
 
F/RT
 
and intercepts ln[
 
k
 
on
 
(0)]
 
 
 
and
 
 
 
ln[
 
k
 
off
 
(0)], respectively. The total
voltage dependence (
 
z
 
total
 
) of the reaction is then 
 
z
 
on 
 
1 
 
z
 
off
 
.
 
The Probability of the Channel Being Open 
 
While the rates of dissociation of ryanodol and 21-amino-9
 
a
 
-
hydroxyryanodine from RyR are independent of 
 
P
 
o
 
, the rates of
association of both ryanodol (data not shown) and 21-amino-9
 
a
 
-
hydroxyryanodine (Tanna et al., 1998) are directly proportional to
channel 
 
P
 
o
 
. For this reason, it is necessary to measure 
 
P
 
o
 
 in all ex-
periments. This was done by monitoring this parameter in the
sections of the recorded data during which no ryanoid was
bound; i.e., with transitions only between the open and closed
conductance levels. 
 
P
 
o
 
 was determined by 50% threshold analysis
as described previously (Sitsapesan and Williams, 1994). To mini-
mize variability in 
 
P
 
o
 
, all experiments were carried out in the
presence of cytosolic EMD 41000. As kinetic parameters deter-
mined for ryanodol are to be compared with equivalent pa-
rameters determined in an earlier investigation for 21-amino-9
 
a
 
-
hydroxyryanodine (Tanna et al., 1998), it is important to correct
for variations in 
 
k
 
on
 
 arising from unavoidable differences in 
 
P
 
o
 
 be-
tween the populations of channels used in the two sets of experi-
ments. The k
 
on values quoted for both ryanodol and 21-amino-
9a-hydroxyryanodine have been normalized to a Po of 1.0.
RESULTS
Is the Interaction of Ryanodol with the RyR Channel 
Inﬂuenced by Transmembrane Holding Potential?
In previous studies, we demonstrated that the interac-
tion of 21-amino-9a-hydroxyryanodine with the high af-
Pmod
1 Pmod –
---------------------
ztFV DGi – []
RT
-------------------------------, exp =
kon V () kon 0 ()  
zon FV RT ¤ () × []
exp · =
koff V () koff 0 ()  
z – off FV RT ¤ () × []
, exp · =4 Voltage Dependence of Ryanoid Binding to Ryanodine Receptor
ﬁnity ryanodine binding site on the RyR channel is in-
ﬂuenced by transmembrane voltage (Tanna et al.,
1998). We observed a marked dependence of Pmod on
voltage with a value of zt obtained from best ﬁt Boltz-
mann distributions (Eq. 3) and from variations in kon
and koff (Eqs. 4 and 5) of z2. As outlined in the intro-
duction, this dependence on holding potential could
arise from the translocation of the positively charged
ryanoid into the voltage drop across the RyR channel.
Alternatively, voltage dependence could be derived
from a voltage-driven movement of charge within the
RyR channel that results in a conformational change
that switches the ryanoid binding site between two
states of different afﬁnity (Tanna et al., 1998). In such a
scheme, the location of the ryanoid binding site could
inﬂuence the measured voltage dependence of a charged
ryanoid such as 21-amino-9a-hydroxyryanodine. If the
site were located outside the voltage drop across the
channel, all of the voltage dependence would be de-
rived from the proposed voltage-driven conformational
change. However, if the site were located within the
voltage drop, a proportion of the total voltage depen-
dence would arise from the movement of the charged
ryanoid into and out of the voltage drop. These alterna-
tives can be distinguished by monitoring the voltage de-
pendence of a ryanoid such as ryanodol that carries no
ionic groups.
Fig. 1 presents the electrical potential of 21-amino-
9a-hydroxyryanodine (right, net charge 11) and ryan-
odol (left, no ionic groups) together with ball and stick
models of the molecules. The top shows positive and
the bottom shows negative electrostatic ﬁelds. 21-
amino-9a-hydroxyryanodine is shown with the pyrrole
ring at the bottom left. Ryanodol, which lacks the pyr-
role ring, is in the same orientation. The wire frames in
all diagrams represent the surface where the electro-
static potential equals 10 kcal/mol. Note the extensive
electrical potential of 21-amino-9a-hydroxyryanodine
(top right) due to the ammonium ion (located in the
upper right of the ball and stick diagram). In compari-
son with ryanodol (top left), the far more extensive
electrical interactions of 21-amino-9a-hydroxyryano-
dine with other molecules is clearly visible. While ryan-
odol is neutral (has no net charge), the presence of hy-
droxyl groups creates a nonuniform distribution of po-
tential in the molecule. The hydroxyl groups on one
surface mean that there will be excess negative electro-
static potential localized to a speciﬁc surface region of
ryanodol. The resulting microscopic dipoles sum to
yield the electrical ﬁelds shown on the left hand ﬁg-
ures. Note that, as for the positive electrostatic ﬁeld,
the distribution of the negative electrostatic potential
(bottom) is much different for 21-amino-9a-hydroxyry-
anodine and ryanodol. Fig. 1 visualizes the large differ-
ence in the macroscopic dipole moments of these two
molecules. The dipole (24.2 Debye) of 21-amino-9a-
hydroxyryanodine runs along the long axis of the cationic
ryanoid (the long axis is parallel to the plane of Fig. 1).
In contrast, the dipole (3.3 Debye) of the neutral ry-
anoid is at right angles to that of 21-amino-9a-hydroxy-
ryanodine. Therefore, these two ryanoids will experi-
ence considerably different torsional forces within any
electrical potential gradient, including the applied
transmembrane voltage. The large permanent dipole
will tend to orient 21-amino-9a-hydroxyryanodine with
the long axis parallel to the electric ﬁeld.
Fig. 2 shows current ﬂuctuations of a single RyR
channel at holding potentials ranging from 250 to 20
mV in the presence of 20 mM ryanodol. As is the case
with 21-amino-9a-hydroxyryanodine, ryanodol interacts
reversibly with the RyR channel, inducing modiﬁca-
tions to both channel gating and ion handling; how-
ever, the fractional conductance of the modiﬁed state
(Tinker et al., 1996) differs for the two ryanoids. The
fractional conductance of ryanodol is independent of
holding potential, being 0.65 6 0.01, 0.64 6 0.02, 0.66 6
0.01, 0.66 6 0.01, 0.66 6 0.01, 0.65 6 0.02, 0.68 6 0.02,
and 0.68 6 0.01 at 260, 250, 240, 230, 220, 210, 10,
and 20 mV. Fractional conductance for 21-amino-9a-
hydroxyryanodine under these conditions is z0.45
(Tanna et al., 1998).
Inspection of the traces in Fig. 2 highlights the ﬁrst
novel ﬁnding of these studies. The probability of RyR
channel modiﬁcation by a neutral ryanoid, ryanodol,
varies markedly with holding potential, and the effect
of voltage is qualitatively the same as that observed with
21-amino-9a-hydroxyryanodine: Pmod for both ryanoids
rises as holding potential is shifted to more positive val-
ues. The relationship between Pmod and holding poten-
tial, in the range 260 to 20 mV, for several channels in
the presence of 20 mM ryanodol is shown in Fig. 3. The
solid line is the best ﬁt Boltzmann distribution (Eq. 3)
obtained by nonlinear regression with a value for zt of
1.54 (r 5 1.0).
Fig. 4 shows the inﬂuence of holding potential on kon
(a) and koff (b) of ryanodol together with equivalent data
for 21-amino-9a-hydroxyryanodine taken from Tanna
et al. (1998). Both the rates of association and dissocia-
tion of ryanodol vary with applied holding potential; kon
increases and koff decreases as the holding potential is
shifted to more positive values. The line of best ﬁt ob-
tained by linear regression for the kon plot has a slope of
0.041 6 0.003 (r 5 1.0), yielding a value of zon of 1.03
(Eq. 4). The equivalent plot for koff has a slope of
20.019 6 0.002 (r 5 0.98), yielding a value for zoff of 0.48
(Eq. 5). Together, these produce a ztotal of 1.51. Values for
kon and koff at 0 mV, obtained from the lines of best ﬁt in
Fig. 4, a and b, are 0.035 mM21 s21 and 0.095 s21, respec-
tively. Fig. 5 shows the relationship of the ryanodol disso-
ciation constant [Kd 5 koff (s21)/kon (mM21 s21)] to trans-5 Tanna et al.
membrane holding potential; 21-amino-9a-hydroxyryan-
odine data are again included for comparison.
The ryanodol data are summarized, together with
equivalent parameters for 21-amino-9a-hydroxyryano-
dine (Tanna et al., 1998), in Table I.
DISCUSSION
Our earlier investigations of the interaction of 21-
amino-9a-hydroxyryanodine with individual cardiac mus-
cle RyR channels demonstrated for the ﬁrst time that
both the association of a ryanoid with its receptor and
dissociation of a ryanoid from its receptor could be sen-
sitive to transmembrane voltage (Tanna et al., 1998).
While the mechanism underlying the observed voltage
dependence was not established, we proposed that
it might result from either the translocation of the
charged ryanoid into the voltage drop across the chan-
nel or a voltage-driven conformational change of RyR
resulting in altered receptor afﬁnity. We have tested
these proposals in this report by monitoring the inﬂu-
ence of voltage on the likelihood of interaction of ryan-
odol, a neutral ryanoid, with the RyR channel.
These experiments establish that transmembrane volt-
age inﬂuences the likelihood of a ryanoid being bound
to the receptor on the RyR channel by a mechanism
that is independent of the translocation of a charged
moiety into the voltage drop across the channel.
A likely mechanism for the modulation of ryanoid in-
Figure 1. (Top) The positive electrostatic ﬁelds of 21-amino-9a-
hydroxyryanodine (right) and ryanodol (left). (Bottom) The neg-
ative electrostatic ﬁelds of the same compounds. In all cases, the
wire frames indicate the surface where the electrical ﬁeld strength
is 10 kcal/mol. Ball and stick models of 21-amino-9a-hydroxyryan-
odine (right) and ryanodol (left) are shown in the same align-
ment. Referring to the models of 21-amino-9a-hydroxyryanodine,
the pyrrole group is at the bottom left and the 21-amino group is
at the top right.
Figure 2. The inﬂuence of holding potential on the probability
of modiﬁcation of RyR channel function by ryanodol. Traces were
obtained from a single RyR channel in symmetrical 610 mM K1
with 20 mM ryanodol in the solution at the cytosolic face of the
channel. O, open; C, closed; ®, modiﬁed.
Figure 3. The relationship between Pmod by ryanodol and hold-
ing potential. Pmod was determined by monitoring dwell times in
the unmodiﬁed and modiﬁed conductance states in 6-min record-
ings with 20 mM ryanodol in the solution at the cytosolic face of
the channel. Each point is the mean 6 SEM of 4–10 experiments.
The curve is the best ﬁt Boltzmann distribution obtained by non-
linear regression with the parameters quoted in the text.6 Voltage Dependence of Ryanoid Binding to Ryanodine Receptor
teraction with the receptor on RyR would then involve
a voltage-dependent equilibrium between receptor states
of different afﬁnity (Tanna et al., 1998). In such a
scheme (Fig. 6), the transmembrane potential would
provide an energy source for the movement of a charged
residue, or domain, of RyR within the electric ﬁeld that
would produce a conformational change and result in
altered receptor afﬁnity. The difference in voltage de-
pendence of kon and koff for ryanodol indicates a degree
of asymmetry in the energy proﬁle for the transition be-
tween the different afﬁnity states of the receptor; the
electrical distance covered by the charged residue in
the forward and reverse reactions may be different, or
the amount of charge moved in the forward and re-
verse reactions may be different due to screening (Mo-
czydlowski, 1986).
While the experiments reported here provide an un-
equivocal demonstration that modulation of ryanoid
binding by voltage is not dependent on the ryanoid car-
rying a positive charge, they do suggest that the net
charge of the ryanoid may produce small quantitative
differences in the inﬂuence of transmembrane voltage.
The total voltage dependence, monitored from varia-
tions in kon and koff, with voltage, of 21-amino-9a-hydroxy-
ryanodine is slightly greater than that of ryanodol, and
this produces a signiﬁcant difference in the inﬂuence
of voltage on the resulting Kds for the two ryanoids.
How could the net charge of the ryanoid alter the inﬂu-
ence of voltage on the interaction of the ligand with its
receptor? The binding of 21-amino-9a-hydroxyryano-
dine may induce a different conformer of the ligand–
RyR complex diagrammed in Fig. 6 than that induced
by ryanodol. The difference in fractional conductance
of the ryanodol–RyR and 21-amino-9a-hydroxyryano-
dine–RyR complexes is evidence of such a difference.
The binding of the two ryanoids may induce different
distributions of charge in the ryanoid–RyR complex, ei-
ther directly by addition of another ionic charge or in-
directly through alteration of one or more of the RyR
acid dissociation constants by interaction with the elec-
tric charge of 21-amino-9a-hydroxyryanodine. The small
difference in voltage dependence of the neutral and
cationic ryanoid indicates that movement of charge is
involved in the voltage-induced transition; however, the
small magnitude of the effect makes interpretation dif-
ﬁcult. While not eliminating the possibility of allosteric
interactions between the ryanodine binding site and
the ion conduction pathway, a mechanism where the
ryanoid binding site is placed within the voltage drop
Figure 4. (a) The dependence of rates of association of ryan-
odol (j) and 21-amino-9a-hydroxyryanodine (n) on holding po-
tential. 20 mM ryanodol was present in the solution at the cytosolic
face of the channel. Each point is the mean 6 SEM of 4–10 exper-
iments. 21-amino-9a-hydroxyryanodine data is from Tanna et al.
(1998), with all values of kon normalized for a Po of 1.0. (b) The de-
pendence of rates of dissociation of ryanodol (j) and 21-amino-
9a-hydroxyryanodine (n) on holding potential. 20 mM ryanodol
was present in the solution at the cytosolic face of the channel.
Each point is the mean 6 SEM of 4–10 experiments. 21-amino-9a-
hydroxyryanodine data is from Tanna et al. (1998). The solid lines
in both a and b were obtained by linear regression with the param-
eters quoted in the text.
Figure 5. The relationship of the dissociation constant [Kd 5 koff
(s21)/kon (mM21 s21)] of ryanodol (j) and 21-amino-9a-hydroxy-
ryanodine (n) to the transmembrane holding potential.7 Tanna et al.
across the channel is appealing because of its simplicity.
Under these circumstances, the small increase in volt-
age dependence arises from the movement of a charged
ryanoid into and/or out of the electric ﬁeld. A location
of the ryanoid binding site within the voltage drop of
RyR would be consistent with the proposal that the re-
ceptor site is within the conduction pathway of the
channel. The conduction pathway of the RyR channel
is almost certainly formed from residues within the car-
boxyl terminal domains of the four RyR monomers that
together make up the functional homotetramer (Bhat
et al., 1997; Zhao et al., 1999) and investigations involv-
ing the proteolytic digestion of channels labeled with
[3H]ryanodine or a [3H]photoactivated derivative of ry-
anodine have established that the high afﬁnity ryano-
dine binding site on the skeletal muscle isoform of RyR
(RyR1) is located at the carboxyl terminus of the mole-
cule (Callaway et al., 1994; Witcher et al., 1994). Very
recent experiments indicate that mutations around the
probable pore-forming region of the RyR channel pro-
duce reductions or abolition of the binding of [3H]ryano-
dine and could be interpreted as indicating this region
as a component of the ryanoid binding site (Zhao et al.,
1999).
In addition, several features of the interaction of ry-
anoids with the RyR channel are consistent with the
proposal that the high-afﬁnity binding site for these
ligands is located within the conduction pathway of the
channel. The magnitude of equilibrium [3H]ryanodine
binding is altered by interventions that modify RyR
channel Po. Activating ligands such as Ca21, caffeine,
and ATP increase binding while ligands that lower Po,
such as Mg21 and ruthenium red, reduce binding (Chu
et al., 1990; Holmberg and Williams, 1990; Hawkes et
al., 1992; Meissner and El-Hashem, 1992). These obser-
vations have given rise to the proposal that the high af-
ﬁnity binding site for [3H]ryanodine is only accessible
when the channel is open and, as a consequence, equi-
librium [3H]ryanodine binding is used routinely as a
method of assessing the Po of RyR channels. A direct
demonstration that the high-afﬁnity binding of a ry-
anoid to the RyR channel requires the channel to be
open was provided in the studies of Tanna et al. (1998),
in which a linear dependence of the rate of association
of 21-amino-9a-hydroxyryanodine on RyR channel Po
was demonstrated.
The dissociation constants monitored in these single-
channel experiments are in the same range as those de-
termined for RyR in intact cardiac sarcoplasmic reticu-
lum membrane vesicles in competition binding studies
with [3H]ryanodine [2 mM 21-amino-9a-hydroxyryano-
dine (Welch, W., unpublished results) and 1 mM ryan-
odol (Welch et al., 1997)]. The good agreement of the
dissociation constants determined by two very different
methods indicates that the parameters determined for
individual RyRs in planar bilayers are relevant to the re-
ceptor in the native SR membrane. Using the values in
TABLE I
The Influence of holding Potential on the Interaction of Ryanodol and 21-Amino-9a-Hydroxyryanodine with Sheep RYR2
Ryanodol 21-Amino-9a-Hydroxyryanodine
Slope (zonF/RT) 0.041 6 0.003 (r 5 1.0) 0.051 6 0.002 (r 5 1.0)
zon 1.03 1.29
Slope (2zonF/RT) 20.019 6 0.002 (r 5 1.0) 20.0344 6 0.002 (r 5 1.0)
zoff 0.48 0.87
ztotal 1.51 2.16
kon at 0 mV (mM21 s21) 0.035 0.365
koff at 0 mV (s21) 0.095 0.990
Kd at 0 mV (mM) 2.81 2.79
Data for 21-amino-9a-hydroxyryanodine are from Tanna et al. (1998) with values of kon normalized for a Po of 1.0.  Values of kon, koff, and Kd at 0 mV are
calculated from the regression lines fitted to data in Figs. 4 and 5. 
Figure 6. Scheme summarizing the inﬂuence of transmem-
brane voltage on the interaction of ryanoids with the high afﬁnity
binding site of RyR (based on information presented in this com-
munication and Tanna et al., 1998). The ryanoid binding site is
only available when the channel is open and only accessible from
the cytosolic side of the channel. L represents the ligand (any ry-
anoid), and 1 and 2 indicate the application of positive and nega-
tive potential to the cytosolic side of the channel. A minimum of
two forms of the vacant receptor exist in this model (low afﬁnity,
open RyR; high afﬁnity, open RyR*). Increasing positive potential
shifts the equilibrium toward open RyR* by increasing the value of
the equilibrium constants K3 and K4. If the ryanoid binding site is
located within the voltage drop across the channel, then charged
ryanoids such as 21-amino-9a-hydroxyryanodine will experience
an additional inﬂuence of voltage.8 Voltage Dependence of Ryanoid Binding to Ryanodine Receptor
Table I, the difference in binding energy of the two ry-
anoids is only 4 cal/mol. The small difference in bind-
ing energy demonstrates that the differences in chan-
nel function observed with 21-amino-9a-hydroxyryano-
dine and ryanodol are more likely to result from the
detailed differences in electrical and steric interactions
between the receptor and ligand rather than from dif-
ferences in the global ryanoid–RyR interaction energy.
Note that compared with ryanodine (Kd 5 2 nM; Welch
et al., 1997), the high dissociation constant of 21-
amino-9a-hydroxyryanodine arises from a 4 kcal/mol
unfavorable interaction between the ligand and recep-
tor (either electrostatic repulsion, poor solvation, or
both). Steric interactions can be discounted since plac-
ing the bulky BODIPY derivative at the 21 position
caused only a small perturbation in binding (Welch et
al., 1994). In contrast, the 4 kcal/mol reduction in
binding energy of ryanodol compared with ryanodine
is due to the loss of the pyrrole carbonyl. That is, while
relative to ryanodine, both ryanodol and 21-amino-9a-
hydroxyryanodine have 4 kcal/mol less binding energy;
this results in one case from the omission of an impor-
tant interaction, while in the other case it is due to the
addition of an unfavorable interaction.
Independent of voltage-induced changes, there are
very marked differences in both the rates of association
and dissociation for ryanodol and 21-amino-9a-hydroxy-
ryanodine with RyR. For example, at a holding poten-
tial of 0 mV, ryanodol is z103 less likely to associate
(DDG  5 1.4 kcal/mol) with the ryanodine binding
site on RyR than 21-amino-9a-hydroxyryanodine; once
bound, ryanodol leaves this site z103 slower (DDG 5
1.4 kcal/mol) than 21-amino-9a-hydroxyryanodine.
Therefore, the difference in energy barriers limiting as-
sociation with and dissociation from the ryanoid bind-
ing site is considerably greater than the difference in
total binding energy of the two ryanoids.
In summary, the experiments described in this report
were designed to examine the mechanisms involved in
the striking inﬂuence of transmembrane holding po-
tential on the interaction of ryanoids with the high af-
ﬁnity binding site on the RyR channel. Our earlier ob-
servation of a strong inﬂuence of voltage on the inter-
action of a positively charged ryanoid with RyR could
be explained either by the movement of the charged
ligand into the voltage drop of the channel to reach its
binding site and/or a voltage-driven conformational al-
teration in RyR leading to altered afﬁnity of the recep-
tor. Here we demonstrate that the apparent dissocia-
tion constant for the neutral ryanoid, ryanodol, de-
creases as the potential at the cytosolic face of the
channel is made increasingly positive, and that this re-
sults from alterations to both the rates of association of
ryanodol with its receptor and dissociation of ryanodol
from its receptor. This observation provides very strong
evidence in support of a voltage-driven alteration in ry-
anoid receptor afﬁnity as the major determining factor
in the inﬂuence of transmembrane holding potential
on the interactions of ryanoids with RyR (Fig. 6).
While this mechanism underlies the inﬂuence of volt-
age on the interaction of both neutral and positively
charged ryanoids, our experiments indicate that a
small additional voltage-dependent effect can be ob-
served with the positively charged 21-amino-9a-hydroxy-
ryanodine. This may reﬂect the movement of the
charged moiety from the cytosolic bulk solution to a
binding site within the voltage drop across the channel,
presumably in the conduction pathway of the channel.
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